Merocarb

Meropenem, the active ingredient in Merocarb, is a carbapenem antibiotic presented as an intravenous solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, hospital‑acquired pneumonia, bacterial meningitis, severe sepsis and complicated urinary tract infections in hospitalized patients.

GNH USA supplies Merocarb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable, timely, efficient logistics for global distribution.

Merocarb (meropenem) is a carbapenem antibiotic used to treat serious bacterial infections.

- Complicated intra‑abdominal infection: achieves clinical cure and microbiological eradication in severe abdominal sepsis. - Complicated urinary tract infection: effective in resolving infections resistant to other agents. - Hospital‑acquired pneumonia: provides rapid bacterial clearance in ventilated patients. - Bacterial meningitis: penetrates the cerebrospinal fluid to treat central nervous system infections. - Severe sepsis: supports systemic infection control when broad‑spectrum coverage is required.

Adverse reactions to Merocarb may vary in frequency and severity.

Common Side Effects: - Nausea - Vomiting - Diarrhea - Rash - Headache - Elevated liver enzymes

Serious or Rare Side Effects: - Seizures, especially in patients with renal impairment - Anaphylactic or severe hypersensitivity reactions - Clostridioides difficile‑associated colitis - Neutropenia or leukopenia - Acute renal failure - Hepatotoxicity

When using Merocarb, clinicians should consider several precautionary measures to ensure safe therapy.

- Renal function: adjust dose in patients with impaired renal function. - Allergy: avoid in individuals with known hypersensitivity to carbapenems or β‑lactams. - Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. - Concomitant antibiotics: monitor for antagonistic effects when combined with bacteriostatic agents. - Superinfection: be aware of the risk of fungal or Clostridioides difficile overgrowth. - Store at ambient temperature: keep in the original container, protect from light and moisture.

Merocarb can interact with other medicines, requiring attention to dosage and monitoring.

Major Interactions (Avoid): - Valproic acid: co‑administration may lower valproate levels and precipitate seizures. - Phenobarbital: induces hepatic enzymes, reducing meropenem exposure. - Aminoglycosides: combined use may increase nephrotoxicity risk.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor renal function and electrolytes. - Warfarin: observe INR for potential anticoagulation changes. - Probenecid: may increase meropenem plasma concentrations.